The Growth Direct® System, a rapid microbial method, is designed for QC testing requiring high capacity and speed. The rapid microbial testing applications include environmental monitoring, bioburden testing, water testing, and sterility testing.
The high-volume testing often found in the combination of air, surface, and personnel monitoring can create headaches for busy labs using time-consuming manual processes. The Growth Direct® System enables fast, accurate enumeration and digitization, boosting your productivity while eliminating manual sample analysis and error-prone recordkeeping steps.
To test and analyze high volumes of water, the Growth Direct® System automates sample enumeration, tracking, and reporting. Our novel growth-based technology helps meet stringent regulatory requirements—integrating advanced robotic automation, powerful optical imaging, algorithmic vision analysis, and data management to ensure product quality and data integrity.
A critical QC step for contamination detection, bioburden testing can fall short of today's demands if you're still using traditional compendium methods. The Growth Direct® System automates incubation and reading of test samples for fast detection of microbial growth at a much earlier stage of colony development, while digitizing results to ensure data integrity.
The only fully automated,
non-destructive platform for rapid sterility testing, the Growth Direct® Rapid Sterility System is designed to deliver a TTD (time-to-detect) in as little as 12 hours. Much faster than the traditional method requiring a 14-day endpoint incubation, it also provides final results in as little as 1-3 days.
The increasing complexity of biologics and sterile injectable drugs makes robust contaminant testing a must to ensure manufacturing uptime and needed drug supplies. However, this complexity also makes biologics susceptible to microbial contamination, lengthy investigations, and recalls. The Growth Direct® System can help you accelerate production, meet stringent quality requirements, and maximize capacity to meet growing global demand.
New therapies must strike a balance between unique complexities and urgent turnaround from sample collection to patient infusion. Setting new standards for automation, sterility, speed, and quality, the Growth Direct® System can help accelerate identification, resolution, and final QC micro results to speed release of life-saving therapeutics—while positively impacting your bottom line, reputation, and competitiveness.